KORU Medical Systems, Inc. KRMD
KORU Medical Systems, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
KORU Medical Systems, Inc. trades at about 330× earnings — above its 10-year norm (10-year range 10×–594×, median 17×).
Shaded band = 10-year range (10×–594×); dot = today's 330×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 62.3% | 63.4% | 58.6% | 55.1% | 58.6% | 61.8% | 64.1% | 62.3% | 61.6% | 62.1% |
| Operating margin | -7.2% | -19.2% | -36.0% | -38.6% | -29.9% | -5.2% | 2.5% | 6.7% | -6.0% | 9.6% |
| Net margin | -6.4% | -18.0% | -48.2% | -31.0% | -19.4% | -5.0% | 2.4% | 5.2% | -4.4% | 6.4% |
| FCF margin | — | — | — | — | — | — | — | — | -4.3% | 14.6% |
| Return on assets | -9.4% | -22.3% | -48.3% | -20.5% | -11.0% | -3.0% | 4.1% | 8.6% | -6.5% | 9.3% |
| Return on equity | -15.5% | -36.1% | -67.5% | -27.6% | -12.5% | -3.4% | 5.0% | 10.2% | -8.0% | 11.0% |
| Current ratio | 2.44 | 2.66 | 4.55 | 4.28 | 7.79 | 10.24 | 4.94 | 5.70 | 4.88 | 6.43 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.